Department of Respiratory Medicine, Ohara Healthcare Foundation, Kurashiki Central Hospital, Miwa 1-1-1, Kurashiki, Okayama, 710-8602, Japan.
Department of Respiratory Medicine, Saiseikai Fukuoka General Hospital, Tenjinn 1-3-46, Chuoku, Fukuoka, Fukuoka, 810-0001, Japan.
BMC Pulm Med. 2017 Dec 16;17(1):211. doi: 10.1186/s12890-017-0559-3.
Because of a limited number of reports, we aimed to investigate the clinical characteristics of patients with Legionella pneumonia due to non-Legionella pneumophila serogroup 1 and the diagnostic usefulness of the six-point scoring system for such patients compared with patients with pneumonia caused by L. pneumophila serogroup 1.
We retrospectively analysed patients diagnosed with Legionella pneumonia due to non-L. pneumophila serogroup 1 between March 2001 and June 2016. We examined the clinical characteristics, including symptoms, laboratory findings, radiologic findings, pneumonia severity, initial treatment and prognosis. We also calculated scores using the six-point scoring system in these patients. Furthermore, we compared the clinical characteristics and six-point scores between non-L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients among hospitalized community-acquired pneumonia patients enrolled prospectively between October 2010 and July 2016.
Eleven patients had pneumonia due to non-L. pneumophila serogroup 1; their median age was 66 years and 8 patients (72.7%) were male. The most common pathogen was L. pneumophila serogroup 3 (6/11), followed by L. pneumophila serogroup 9 (3/11), L. pneumophila serogroup 6 (1/11) and L. longbeachae (1/11). Non-specific symptoms, such as fever and cough, were common. Six patients (54.5%) had liver enzyme elevation, but no patient developed hyponatraemia at <130 mEq/L. Nine patients (81.8%) showed lobar pneumonia and 7 patients (63.6%) manifested with consolidation and ground-glass opacity. Patients with mild to moderate severity comprised 10 (90.9%) by CURB-65 and 5 (45.5%) by the Pneumonia Severity Index. Of all patients, 4 were admitted to the intensive care unit and 3 died despite appropriate empiric therapy. The clinical characteristics were not significantly different between non-L. pneumophila serogroup 1 patients and L. pneumophila serogroup 1 patients (n = 23). At a cut-off value of ≥ 2 points, the sensitivity of the six-point scoring system was 54.5% (6/11) for non-L. pneumophila serogroup 1 patients and 95.7% (22/23) for L. pneumophila serogroup 1 patients.
Cases of non-L. pneumophila serogroup 1 pneumonia varied in severity from mild to severe and the clinical characteristics were often non-specific. The six-point scoring system was not useful in predicting such Legionella pneumonia cases.
由于报告数量有限,我们旨在研究非嗜肺军团菌血清群 1 引起的军团菌肺炎患者的临床特征,以及与嗜肺军团菌血清群 1 引起的肺炎患者相比,该评分系统对这类患者的诊断价值。
我们回顾性分析了 2001 年 3 月至 2016 年 6 月期间诊断为非嗜肺军团菌血清群 1 所致军团菌肺炎的患者。我们检查了这些患者的临床特征,包括症状、实验室检查、影像学检查、肺炎严重程度、初始治疗和预后。我们还使用六点评分系统计算了这些患者的分数。此外,我们比较了 2010 年 10 月至 2016 年 7 月期间前瞻性纳入的住院社区获得性肺炎患者中,非嗜肺军团菌血清群 1 患者和嗜肺军团菌血清群 1 患者的临床特征和六点评分。
11 例患者患有非嗜肺军团菌血清群 1 肺炎;中位年龄为 66 岁,8 例(72.7%)为男性。最常见的病原体是嗜肺军团菌血清群 3(6/11),其次是嗜肺军团菌血清群 9(3/11)、嗜肺军团菌血清群 6(1/11)和长滩军团菌(1/11)。非特异性症状,如发热和咳嗽,较为常见。6 例(54.5%)患者出现肝酶升高,但无患者发生<130mEq/L 的低钠血症。9 例(81.8%)患者表现为大叶性肺炎,7 例(63.6%)表现为实变和磨玻璃影。根据 CURB-65,10 例(90.9%)患者为轻度至中度严重程度,根据肺炎严重程度指数,5 例(45.5%)患者为中度严重程度。所有患者中,4 例入住重症监护病房,尽管接受了适当的经验性治疗,仍有 3 例死亡。非嗜肺军团菌血清群 1 患者与嗜肺军团菌血清群 1 患者的临床特征无显著差异(n=23)。在≥2 分的截断值时,六点评分系统对非嗜肺军团菌血清群 1 患者的敏感性为 54.5%(6/11),对嗜肺军团菌血清群 1 患者的敏感性为 95.7%(22/23)。
非嗜肺军团菌血清群 1 肺炎的严重程度从轻度到重度不等,临床特征通常不具特异性。六点评分系统对预测此类军团菌肺炎病例无帮助。